SUMMARY In 14 healthy volunteers, the addition of 12 g cholestyramine to a vitamin A-containing test meal reduced the expected rise in serum vitamin A by 59.5% (p<0 001). By contrast, lignin had no significant effect in 12 subjects. This study confirms the importance of bile acids in vitamin A absorption and the ineffectiveness of lignin as a sequestrator of conjugated bile acids.
It is generally accepted that the absorption of fatsoluble vitamins is dependent on the presence of a micellar phase and hence of conjugated bile acids in the intestinal lumen (Hofmann, 1968; Heaton, 1972) . It is also well documented that cholestyramine binds conjugated bile acids both in vitro (Johns and Bates, 1970) and in vivo (Kenney and Garbutt, 1970; Heaton, Heaton, and Barry, 1971) . Lignin, a natural phenylpropane polymer present in plant fibre, has undoubted, if rather slow, bile acid-binding activity in vitro, this activity being greater with free than with conjugated bile acids (Eastwood and Hamilton, 1968) . Clinical experience in a small number of cases has suggested that lignin may be effective in two disorders in which cholestyramine is very useful, namely, type II hyperlipoproteinaemia and postileectomy diarrhoea (Thiffault, Belanger, and Pouliot, 1970; Eastwood and Girdwood, 1968) . However, it has not yet been shown that lignin sequestrates conjugated or free bile acids in vivo. In a previous study in normal subjects, we were unable to detect any effect of lignin on the recirculation of radioactively labelled taurocholate and its metabolites (Heaton et al, 1971 (Longenecker and Basu, 1965 smaller in all subjects, markedly so in most cases. The mean increase with cholestyramine was 40 5 ± 17-0% of the increase for the control test (t = 13-07, p< 0o01).
In 12 subjects the five hour increase in serum vitamin A was measured with and without lignin (fig 2) . The increase with lignin was smaller in eight and larger in four subjects. Overall, no significant difference was found. The mean increase with lignin was 93-2 ± 29 5 % of the control test increase (t = 0-798).
If the data are calculated using the peak rise (that is, the highest of the four, five, and six hour values) instead of the five hour rise in serum vitamin A, lignin again produced no significant change, whereas cholestyramine caused a highly significant reduction (mean value with cholestyramine 40 4 ± 15 4% of the control value; t = 14-48, p < 0X001).
Discussion
In this study we have shown that cholestyramine, in an amount equivalent to a modest daily dose, markedly reduces vitamin A absorption as assessed by the vitamin A tolerance test. It acts presumably by removing bile acids from solution and so preventing the formation of a micellar phase in the small bowel lumen. This finding was predictable and confirms earlier preliminary studies (Longenecker and Basu, 1965) . Although cholestyramine is not very palatable, it is unlikely that delayed gastric emptying played a significant role since adding this agent to the test meal did not delay the peak rise in serum vitamin A.
It is probable that cholestyramine also impairs the absorption of the other fat-soluble vitamins D, E, and K. Direct studies of this question are lacking, but cases are on record in which cholestyramine appeared to cause osteomalacia (Heaton, Lever, and Barnard, 1972) and hypoprothrombinaemia (Gross and Brotman, 1970) , which were reversed by treatment with vitamins D and K respectively.
Although the vitamin A tolerance test is crude and unphysiological, the results with cholestyramine show that it can be used to detect pharmacological binding of conjugated bile acids. The failure of lignin, even when given in an amount two or three times greater than the suggested daily dose (Thiffault et al, 1970; Eastwood and Girdwood, 1968) , to have any significant effect on the rise in serum vitamin A suggests that in vivo lignin does not bind conjugated bile acids to an important extent. A similar conclusion was reached in a previous study in which lignin failed to accelerate the removal from the enterohepatic circulation of labelled taurocholate and its metabolites (Heaton et al, 1971) .
Small-scale studies have led to the claim that lignin is effective in lowering elevated serum cholesterol levels (Thiffault et al, 1970) and in relieving the bile acid catharsis of ileal resection (Eastwood and Girdwood, 1968) . If these effects are substantiated, the mode of action of lignin must be different from that of cholestyramine. There are marked physicochemical differences between the two materials. Cholestyramine is a polybasic anion exchange resin which is believed to act mainly by exchanging chloride ions for bile acid ions, though a lesser non-electrostatic component has been postulated (Johns and Bates, 1970) . In contrast, lignin is a relatively nonpolar, aromatic polymer, which is thought to act by hydrophobic bonding (Eastwood and Hamilton, 1968) . In vitro, lignin binds most effectively the least polar bile acids and it may be speculated that any therapeutic properties of lignin are due to binding of mono-hydroxy or other bacterially degraded bile acids.
